Latest Announcements

Samhi Hotels Ltd has released its Investor Presentation for Q2 FY27, highlighting strong operating environment, revenue growth, and future growth initiatives.

DAM Capital Advisors Ltd reported Q2 FY27 financial results, with total income increasing 81% q-o-q to INR 54.3 crore, driven by a 262% q-o-q rise in revenue from merchant banking to INR 34.3 crore. The company successfully completed 5 IPO transactions, including 2 sole banker mandates, and has a healthy pipeline of mandates.

Metropolis Healthcare Limited has reported strong Q2 FY27 performance with revenue up 16% to ₹497 crore and PAT up 43% to ₹75 crore.

Lloyds Metals And Energy Limited has announced its Q2 & H1 FY27 earnings presentation, showcasing strong growth in revenue, EBITDA, and PAT, driven by higher iron ore EC limits, faster ramp-up of the pellet plant, and improved sponge iron volumes.

Hero MotoCorp celebrates 25 years of global leadership, unveils next-generation premium portfolio, and accelerates global mobility ambitions at EICMA 2026.

DAM Capital Advisors Limited has announced its financial results for the quarter and half-year ended September 30, 2026, with a total income of INR 54.3 crore, up 81% q-o-q, and a PAT of INR 13.5 crore, with a PAT margin of 25.0%.

Hero MotoCorp Ltd announced its 25th consecutive year of global leadership, unveiling new motorcycles, commencing VIDA's European operations, and introducing Novus Labs, a dedicated innovation hub for the future of mobility.

Computer Age Management Services Ltd reported Q2 FY27 earnings with 10% year-on-year revenue growth, 13.5% EBITDA growth, and 14.5% PAT growth. The company's non-MF business grew 22% and CAMSPay contributed 6% to revenue.

Metropolis Healthcare Ltd reported strong Q2 FY27 performance with revenue up 16% to ₹497 crore and PAT up 43% to ₹75 crore.

DAM Capital Advisors Ltd has announced its investor presentation for the quarter and half year ended September 30, 2026, showcasing a 81.0% Q-o-Q growth in total income to ₹ 54.3 Cr, with profit after tax increasing to ₹ 13.5 Cr. The company has a strong pipeline of 19 IPOs and has executed 8 ECM transactions in Q2 FY27, raising ₹ 30,500+ Cr.

Endurance Technologies Ltd has announced its unaudited financial results for the quarter and half year ended 30th September, 2026, showing a 31.6% increase in consolidated total income and a 14.4% increase in consolidated PAT.

Multi Commodity Exchange of India Ltd has announced its un-audited financial results for the quarter and half year ended September 30, 2026, with the board meeting outcome indicating a positive financial performance.

Dam Capital Advisors Limited has announced its investor/analyst presentation for the quarter and half-year ended September 30, 2026, with total income of ₹ 54.3 Cr in Q2 FY27, a 81.0% Q-o-Q growth, and profit after tax of ₹ 13.5 Cr.

Metropolis Healthcare Ltd has announced its Q2 and H1FY27 investor presentation, showcasing strong revenue growth, increased EBITDA margins, and sustained demand momentum. The company has delivered mid-teen revenue growth, outperforming its guidance, driven by throughput from the expanded Lab & Center network, operating leverage, automation, and productivity gains.

Lupin Ltd has launched Raltegravir Tablets, USP, 600 mg in the United States, following approval from the U.S. FDA. The product is eligible for 180-day generic drug exclusivity and has an estimated annual sale of USD 26 million in the U.S.

Bandhan Bank Ltd has announced its unaudited financial results for Q2 and H1 FY27, with a 13% YoY growth in loan book and stabilization of EEB portfolio. The bank has also launched its credit card business with four variants.

GSPL Transmission Limited has reported an 8.5% YoY revenue growth in Q2 FY27, driven by higher transport volumes across HP, LP and HAPI networks. The company has also announced an expansion led capex plan of INR 3,500 crore to enhance pipeline capacity to new geographical areas.

Lupin Limited has launched Raltegravir Tablets, USP, 600 mg in the United States, following approval from the U.S. FDA. The company is eligible for 180-day generic drug exclusivity.

Computer Age Management Services Limited reported Q2 and H1 FY27 earnings, with operating revenue growing 10% year-on-year to INR415 crores, EBITDA increasing 13.5% to INR191 crores, and PAT growing 14.5% year-on-year. The non-MF business grew 22%, with CAMSPay contributing 6% to revenue.

Endurance Technologies Limited has announced its unaudited financial results for the quarter and half year ended 30th September, 2026, showing a 31.6% increase in consolidated total income and a 14.4% increase in consolidated PAT.